BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19540315)

  • 21. Genistein induces receptor and mitochondrial pathways and increases apoptosis during BCL-2 knockdown in human malignant neuroblastoma SK-N-DZ cells.
    George J; Banik NL; Ray SK
    J Neurosci Res; 2010 Mar; 88(4):877-86. PubMed ID: 19813266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticancer efficacy of p-dodecylaminophenol against high-risk and refractory neuroblastoma cells in vitro and in vivo.
    Takahashi N; Koyama S; Hasegawa S; Yamasaki M; Imai M
    Bioorg Med Chem Lett; 2017 Oct; 27(20):4664-4672. PubMed ID: 28927789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-(4-Hydroxyphenyl) retinamide induced both differentiation and apoptosis in human glioblastoma T98G and U87MG cells.
    Das A; Banik NL; Ray SK
    Brain Res; 2008 Aug; 1227():207-15. PubMed ID: 18602901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bcl-2 inhibitor and apigenin worked synergistically in human malignant neuroblastoma cell lines and increased apoptosis with activation of extrinsic and intrinsic pathways.
    Karmakar S; Davis KA; Choudhury SR; Deeconda A; Banik NL; Ray SK
    Biochem Biophys Res Commun; 2009 Oct; 388(4):705-10. PubMed ID: 19695221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactive Oxygen Species Mediates the Synergistic Activity of Fenretinide Combined with the Microtubule Inhibitor ABT-751 against Multidrug-Resistant Recurrent Neuroblastoma Xenografts.
    Chen NE; Maldonado NV; Khankaldyyan V; Shimada H; Song MM; Maurer BJ; Reynolds CP
    Mol Cancer Ther; 2016 Nov; 15(11):2653-2664. PubMed ID: 27530131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cisplatin-induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC-3 pancreatic tumor xenografts.
    Mohammad RM; Banerjee S; Li Y; Aboukameel A; Kucuk O; Sarkar FH
    Cancer; 2006 Mar; 106(6):1260-8. PubMed ID: 16475211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in expression of specific microRNAs by combination of 4-HPR and EGCG inhibited growth of human malignant neuroblastoma cells.
    Chakrabarti M; Khandkar M; Banik NL; Ray SK
    Brain Res; 2012 May; 1454():1-13. PubMed ID: 22498172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
    Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB
    Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
    Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F
    Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PI3K Inhibitor Combined With Chemotherapy Can Enhance the Apoptosis of Neuroblastoma Cells In Vitro and In Vivo.
    Geng X; Xie L; Xing H
    Technol Cancer Res Treat; 2016 Oct; 15(5):716-22. PubMed ID: 26224681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of reactive oxygen species in 2-methoxyestradiol-induced apoptosis in human neuroblastoma cells.
    Zhang Q; Ma Y; Cheng YF; Li WJ; Zhang Z; Chen SY
    Cancer Lett; 2011 Dec; 313(2):201-10. PubMed ID: 21978530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma.
    Bayat Mokhtari R; Baluch N; Ka Hon Tsui M; Kumar S; S Homayouni T; Aitken K; Das B; Baruchel S; Yeger H
    BMC Cancer; 2017 Feb; 17(1):156. PubMed ID: 28235409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthetic lethal screen identifies NF-κB as a target for combination therapy with topotecan for patients with neuroblastoma.
    Tsang PS; Cheuk AT; Chen QR; Song YK; Badgett TC; Wei JS; Khan J
    BMC Cancer; 2012 Mar; 12():101. PubMed ID: 22436457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) and Genistein is effective in inhibiting pancreatic cancer growth.
    Nozawa F; Itami A; Saruc M; Kim M; Standop J; Picha KS; Cowan KH; Pour PM
    Pancreas; 2004 Jul; 29(1):45-52. PubMed ID: 15211111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The chemopreventive agent N-(4-hydroxyphenyl)retinamide induces apoptosis through a mitochondrial pathway regulated by proteins from the Bcl-2 family.
    Boya P; Morales MC; Gonzalez-Polo RA; Andreau K; Gourdier I; Perfettini JL; Larochette N; Deniaud A; Baran-Marszak F; Fagard R; Feuillard J; Asumendi A; Raphael M; Pau B; Brenner C; Kroemer G
    Oncogene; 2003 Sep; 22(40):6220-30. PubMed ID: 13679861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The novel melphalan prodrug J1 inhibits neuroblastoma growth in vitro and in vivo.
    Wickström M; Johnsen JI; Ponthan F; Segerström L; Sveinbjörnsson B; Lindskog M; Lövborg H; Viktorsson K; Lewensohn R; Kogner P; Larsson R; Gullbo J
    Mol Cancer Ther; 2007 Sep; 6(9):2409-17. PubMed ID: 17876040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survivin knockdown and concurrent 4-HPR treatment controlled human glioblastoma in vitro and in vivo.
    George J; Banik NL; Ray SK
    Neuro Oncol; 2010 Nov; 12(11):1088-101. PubMed ID: 20679253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P450 inhibitor ketoconazole increased the intratumor drug levels and antitumor activity of fenretinide in human neuroblastoma xenograft models.
    Lopez-Barcons L; Maurer BJ; Kang MH; Reynolds CP
    Int J Cancer; 2017 Jul; 141(2):405-413. PubMed ID: 28340497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2.
    Delia D; Aiello A; Formelli F; Fontanella E; Costa A; Miyashita T; Reed JC; Pierotti MA
    Blood; 1995 Jan; 85(2):359-67. PubMed ID: 7811993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation.
    Ponzoni M; Bocca P; Chiesa V; Decensi A; Pistoia V; Raffaghello L; Rozzo C; Montaldo PG
    Cancer Res; 1995 Feb; 55(4):853-61. PubMed ID: 7850799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.